Preferred Label : Implant Dosage Form;

NCIt synonyms : Implant; Implant Dose Form; Imp;

NCIt definition : A solid intended for insertion securely within the body.;

Alternative definition : CDISC: A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI); EDQM-HC: Solid sterile preparation of a size and shape suitable for implantation. It may be prepared by moulding or other means other than compression. Each implant is presented in a sterile container that may be provided with an administration device. Implants are intended for release over an extended period of time in order to obtain local or systemic effect. 'Implantation tablet', 'Implantation chain' and 'Implantation matrix' are excluded.;

FDA table : Dosage Form (C-DRG-00201);

Codes from synonyms : 715; 11301000;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3487184/fr/provox-xtrahme
2024
France
health technology assessment
Patient was not Postmenopausal with no Prior Oophorectomy
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Caffeine Not Routinely Consumed
MGMT Promoter Methylation Testing Was Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Norway
IDH Family Wildtype
Adjuvant Post-operative Chemotherapy Was Not Administered
Implant Dosage Form
Chemotherapy Not Received
Paraneoplastic Syndrome is Not Present
NON Mouse
PTEN Gene Mutation Negative
Cancer History Absent
KRAS Mutation Analysis Was Not Performed
Any Metastatic Diagnosis Absent
TP53 Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Additional Molecular Studies Were Not Performed
Physician Diagnosed Diabetes Absent
No History of Gestational Complication
Radiation History Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Chief Complaint Not Caused by Trauma
Family History of Stomach Cancer Absent
History of Medical Treatment Absent
Implant Device Component
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
BRAF Rearrangement Analysis Was Not Performed
implant, nos
10q23/PTEN Locus Deletion Analysis Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
KIT Mutation Analysis Was Not Performed
Implant
MET Mutation Analysis Was Not Performed
Administration via Implantation
Medication Not Taken
SDH Complex Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation Therapy Not Received
NRAS Mutation Analysis Was Not Performed
Has No Sibling
Negation
ATRX Gene Mutation Negative
Neither Case or Control Status
No History of Congenital Heart Disease
Implant Dosing Unit
New Disease is not Multifocal
Other Preoperative IV Medications were not Administered
Lymph Node Dissection Was Not Performed
prostheses and implants
EGFR Mutation Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
Regional Anesthesia was not Administered
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Radiation Therapy Was Not Administered
First Degree Family History Thyroid Cancer Negative
ATRX Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
Chemical/Occupational Exposure Absent
ALK Rearrangement Analysis Was Not Performed
Preoperative IV Opiates were not Administered
Not Lost to Follow-Up
No History of Neonatal Complication
Additional Surgery for New Tumor Event Absent
Nitric Oxide Measurement
Another Form of Birth Control was not Used
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Fluorescence In Situ Hybridization Was Not Performed
prosthesis, nos
Respiratory System Finding
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
IDH Family Mutation Analysis Was Not Performed
First Degree Family History Cancer Negative
No History of Rheumatic Fever
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No History of Non-Cardiac Surgery
1p/19q Deletion Analysis Was Not Performed
Implant Dosage Form Category
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
PTEN Mutation Analysis Was Not Performed
Unemployed
Intervention Not Given for Kawasaki Disease
EGFR Gene Amplification Negative
Patient was Not Previously Evaluated for Current Chief Complaint
Hypertension Absent
Documentation Absent
First Degree Family History of Primary Brain Tumor Negative
Therapeutic Ionizing Radiation to Head History Absent
NF1 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
PDGFRA Mutation Analysis Was Not Performed
Chief Complaint was Not Witnessed
Preoperative IV Antiemetics were not Administered
Adjuvant Post-operative Immunological Therapy Was Not Administered
Additional Immunohistochemistry Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Respiratory System
Intercurrent Illness is Absent at Onset of Chief Complaint
Preoperative IV Sedation was Not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Nitric Oxide
Neither
Prosthesis Device Component
No Known History of Illicit Drug Use
No Response to Intervention for Kawasaki Disease
BRAF Mutation Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
History of Colorectal Cancer Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Routine Cytogenetics Were not Completed
ERBB2 Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
Preoperative IV Antacids were not Administered
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
No History of Kawasaki Disease
Use of Smokeless Tobacco at Time of Diagnosis Negative
Tumor Reoccurrence Absent After Initial Treatment
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
No History of Myopathy
ROS1 Rearrangement Analysis Was Not Performed

---
https://www.has-sante.fr/jcms/p_3508495/fr/macroplastique
2024
France
health technology assessment
dimethicone
Implant Dosage Form Category
polydimethylsiloxane
implant, nos
Implant
prostheses and implants
Administration via Implantation
Ureteral Route of Administration
Implant Dosage Form
Implant Device Component
ureter, nos
Implant Dosing Unit
dimethylpolysiloxanes

---
https://www.cochrane.org/fr/CD012079/MENSTR_pour-reparer-le-prolapsus-vaginal-faut-il-utiliser-des-treillis-vaginaux-des-implants-biologiques-ou
2024
United Kingdom
review of literature
french abstract
Vaginal Dosage Form
Implantation
Vaginal Route of Administration
Israel
Tissue
What Month is it
tissues
System User
Biological Son
Biology
natives
Administration via Implantation
Interleukin
Implant Device Component
Biological Challenge Agent
Implant Dosage Form
Implanter Device
Implant Dosage Form Category
Biological
vagina, nos
prolapse of vaginal walls without uterine prolapse
population groups
Prolapse
prostheses and implants
Illinois
biology
Biotechnology
Use
Implantation Method of Administration
biology
uterine prolapse
Biological or Textual Reference to Actual Test or Parameter
Implanted Medical Device
Implant Dosing Unit
Vaginal
implant, nos
vaginal prolapse
Implant
Biological Agent

---
https://www.has-sante.fr/jcms/p_3503151/fr/i-stop
2024
France
health technology assessment
Implant Dosage Form
Tryptophan 2,3-Dioxygenase
Implant Device Component
Stage I Cervical Cancer AJCC v8
Streak
Administration via Implantation
Stop
Ladd Band
Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
suburethral slings
Iodide
Strip Dosage Form
urethra, nos
Stage I Bladder Cancer AJCC v8
Implant
Test Strip Device
Implanted Medical Device
Cease
Implant Dosage Form Category
ISS Stage I Multiple Myeloma
Retropubic
Treatment Environmental Setting
Stage I Intrahepatic Cholangiocarcinoma AJCC v8
RELT wt Allele
Inch
Clark Level I
Stage I Distal Bile Duct Cancer AJCC v8
Implantation
implant, nos
Intraurethral Route of Administration
MATCH Arm EAY131-I
Implanter Device
Stage I Hilar Cholangiocarcinoma AJCC v8
Stage I Prostate Cancer AJCC v8
Implant Dosing Unit
Iodine
Stage I Uveal Melanoma AJCC v7
Implantation Method of Administration

---
https://www.has-sante.fr/jcms/p_3503163/fr/propel-mini
2024
France
health technology assessment
Administration via Implantation
Implant Dosage Form Category
Mometasone Furoate
Implant Dosage Form
prostheses and implants
Implant
Implant Device Component
mometasone furoate
Implant Dosing Unit
Mometasone Furoate
implant, nos

---
https://www.has-sante.fr/jcms/p_3503148/fr/propel-contour
2024
France
health technology assessment
Implant
mometasone furoate
Mometasone Furoate
prostheses and implants
Administration via Implantation
implant, nos
Implant Dosing Unit
Implant Dosage Form
Implant Device Component
Contour
Implant Dosage Form Category
Mometasone Furoate

---
https://www.has-sante.fr/jcms/p_3501896/fr/propel
2024
France
health technology assessment
Mometasone Furoate
Implant Device Component
Implant Dosage Form Category
Administration via Implantation
Implant Dosing Unit
Mometasone Furoate
Implant
prostheses and implants
mometasone furoate
implant, nos
Implant Dosage Form

---
https://www.has-sante.fr/jcms/p_3502975/fr/edwards-sapien-3
2024
France
health technology assessment
implant, nos
Implanter Device
Implantation
Implant
Device System
CDISC SDTM Route of Administration Terminology
Implantation Method of Administration
Sontuzumab
Implant Dosage Form
aorta, nos
Aorta
aorta
Drug Delivery System Category
Implanted Medical Device
Implant Device Component
systemic administration
leadership
Administration via Implantation
Drug Delivery System
bioprosthesis
Implant Dosing Unit
Implant Dosage Form Category

---
https://www.has-sante.fr/jcms/p_3509307/fr/ams-800
2024
France
health technology assessment
mesenteric artery, superior
Implant Device Component
Uganda
prostheses and implants
TWIST2 wt Allele
Implant Dosage Form Category
implant, nos
Supplementary Motor Area
multiple system atrophy
Implant Dosage Form
Accelerator Mass Spectrometry
Implant Dosing Unit
Administration via Implantation
Implant
alpha-Amylases

---
https://www.has-sante.fr/jcms/p_3492674/fr/evolut-fx
2024
France
health technology assessment
TMSB4X wt Allele
Implantation Method of Administration
Murine Artery
Implanter Device
Aorta
Fetal Pathology Findings Domain
Implanted Medical Device
implant, nos
artery, nos
Thymosin Beta-4
Implant Dosage Form Category
F10 wt Allele
Metropolitan France
Sontuzumab
administration, cutaneous
Implant Dosage Form
GFUS wt Allele
Implantation
Alcohol Related Neurodevelopmental Disorder
aorta, nos
arteries
Implant Device Component
bioprosthesis
Artery
aorta
Administration via Implantation
Implant
CDISC SDTM Route of Administration Terminology
Implant Dosing Unit

---
https://www.has-sante.fr/jcms/p_3403886/fr/criteres-d-eligibilite-des-centres-implantant-des-tavis-evaluation-de-2023
2023
France
health technology assessment
Assessment
Implant Dosage Form
Centi
Implanted Medical Device
central
Hub Device
Implanter Device
implant, nos
Implant Device Component
Physical Examination
Implant Dosage Form Category
Evaluation
evaluation studies as topic
Implantation
Center
Implant Dosing Unit
Assessment
Implantation Method of Administration
Administration via Implantation
Implant
prostheses and implants
Clinical Trial Eligibility Criteria

---
https://www.academie-medecine.fr/les-implants-cerebraux-espoir-mais-vigilance/
2023
France
scientific and technical information
cerebrum
Implant Device Component
implant, nos
Hope
Implantation Method of Administration
Precordial Palpation Finding of Thrill
Implant
Cerebral Hemisphere
Implanter Device
Hopelessness
brain, nos
Gemogenovatucel-T
Implantation
hope
wakefulness
Implanted Medical Device
wakefulness
Implant Dosage Form
Implant Dosing Unit
Implant Dosage Form Category
Administration via Implantation
prostheses and implants

---
https://www.has-sante.fr/jcms/p_3477473/fr/hot-axios
2023
France
health technology assessment
electrocoagulation
phenobarbital
Implant Dosage Form
Drug Delivery System Category
Implant Device Component
Device System
Implant Dosing Unit
Drug Delivery System
implant, nos
Electrocauterization
Implant
Mathematical Operator
prostheses and implants
Implant Dosage Form Category
Administration via Implantation
lumen of body system, nos

---
https://www.has-sante.fr/jcms/p_3472149/fr/atoms
2023
France
health technology assessment
Implant Dosage Form
Intraurethral Route of Administration
urethra, nos
Coping
Implant Dosing Unit
Administration via Implantation
Implant
Man
ELL wt Allele
Man Chinese
Urethral Dosage Form
adjustment, nos
humans
homo sapiens
Mandinka Language
Implant Device Component
implant, nos
Implant Dosage Form Category
Male
prostheses and implants
Fecal Immunochemical Test
Adjustment
Pharmacokinetic Parameters Supplemental Qualifiers Dataset

---
https://www.has-sante.fr/jcms/p_3471691/fr/ifuse-3d-implant-system
2023
France
health technology assessment
prostheses and implants
sacroiliac joint
sacroiliac joint
Drug Delivery System Category
Drug Delivery System
Sponsor Study Reference Identifier
implant, nos
Device System
Administration via Implantation
Systemic Immunotherapy
arthrodesis
Implant Device Component
Implant Dosage Form
Sacroiliac Joint
Arthrodesis
Implant Dosing Unit
Implant
Implant Dosage Form Category
arthrodesis, nos

---
https://www.has-sante.fr/jcms/p_3465339/fr/edwards-sapien-3
2023
France
health technology assessment
CDISC SDTM Route of Administration Terminology
Implanter Device
Implant Dosage Form
Implant Dosage Form Category
systemic administration
certain
Implant
Drug Delivery System
Sontuzumab
aorta, nos
Device System
Implantation Method of Administration
bioprosthesis
Drug Delivery System Category
Administration via Implantation
Implant Dosing Unit
aorta
Aorta
Implanted Medical Device
Implant Device Component
Implantation
implant, nos
Certain

---
https://www.has-sante.fr/jcms/p_3460127/fr/lift
2023
France
health technology assessment
Implant Dosage Form
Treatment Environmental Setting
Implant Device Component
Implantation Method of Administration
Tryptophan 2,3-Dioxygenase
urethra, nos
Streak
Administration via Implantation
Intraurethral Route of Administration
Strip Dosage Form
suburethral slings
Implantation
RELT wt Allele
Test Strip Device
Implant Dosage Form Category
Implanter Device
Implant Dosing Unit
Ladd Band
Implant
Retropubic
Implanted Medical Device
implant, nos

---
https://dumas.ccsd.cnrs.fr/dumas-04110149
2023
France
dissertations, academic
prosthetic implant, nos
Implant Dosing Unit
restaurants
review literature as topic
Systematic Review
choice behavior
Gingiva
Repository
Implant
prosthesis implantation
Implant Device Component
dental prosthesis, Implant-Supported
Choose
Implant Dosage Form
Administration via Implantation
Gingival
gum, nos
food services
Reviewing
dental implants, single-tooth
Implant Dosage Form Category
classification

---
Nous contacter.
28/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.